The Concave Shape of the Forced Expiratory Flow-Volume Curve in 3 Seconds Is a Practical Surrogate of FEV₁/FVC for the Diagnosis of Airway Limitation in Inadequate Spirometry

References

1. 1.↵
   1. Pellegrino R,
   2. Viegi G,
   3. Brusasco V,
   4. Crapo RO,
   5. Burgos F,
   6. Casaburi R,
   7. et al

   . Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948–968.

   OpenUrlFREE Full Text
2. 2.↵
   1. Miller MR,
   2. Hankinson J,
   3. Brusasco V,
   4. Burgos F,
   5. Casaburi R,
   6. Coates A,
   7. et al

   . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Eaton T,
   2. Withy S,
   3. Garrett JE,
   4. Mercer J,
   5. Whitlock RM,
   6. Rea HH

   . Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999;116(2):416–423.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Allen S,
   2. Yeung P,
   3. Janczewski M,
   4. Siddique N

   . Predicting inadequate spirometry technique and the use of FEV₁/FEV₃ as an alternative to FEV₁/FVC for patients with mild cognitive impairment. Clin Respir J 2008;2(4):208–213.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Lutfi MF

   . Acceptable alternatives for forced vital capacity in the spirometric diagnosis of bronchial asthma. Int J Appl Basic Med Res 2011;1(1):20–23.

   OpenUrl
6. 6.↵
   1. Ioachimescu OC,
   2. Venkateshiah SB,
   3. Kavuru MS,
   4. McCarthy K,
   5. Stoller JK

   . Estimating FVC from FEV₂ and FEV₃: assessment of a surrogate spirometric parameter. Chest 2005;128(3):1274–1281.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Townsend MC,
   2. Du Chene AG,
   3. Fallat RJ

   . The effects of underrecorded forced expirations on spirometric lung function indexes. Am Rev Respir Dis 1982;126(4):734–737.

   OpenUrlPubMedWeb of Science
8. 8.↵
   1. Mehrparvar AH,
   2. Rahimian M,
   3. Mirmohammadi SJ,
   4. Gheidi A,
   5. Mostaghaci M,
   6. Lotfi MH

   . Comparison of FEV₃, FEV₆, FEV₁/FEV₃ and FEV₁/FEV₆ with usual spirometric indices Respirology 2012;17(3):541–546.

   OpenUrlPubMed
9. 9.↵
   1. Wildhaber JH,
   2. Sznitman J,
   3. Harpes P,
   4. Straub D,
   5. Möller A,
   6. Basek P,
   7. Sennhauser FH

   . Correlation of spirometry and symptom scores in childhood asthma and the usefulness of curvature assessment in expiratory flow-volume curves. Respir Care 2007;52(12):1744–1752.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Majak P,
    2. Cichalewski L,
    3. Ożarek-Hanc A,
    4. Stelmach W,
    5. Jerzyńska J,
    6. Stelmach I

    . Airway response to exercise measured by area under the expiratory flow-volume curve in children with asthma. Ann Allergy Asthma Immunol 2013;111(6):512–515.

    OpenUrl
11. 11.
    1. Zapletal A,
    2. Hladíková M,
    3. Chalupová J,
    4. Svobodová T,
    5. Vávrová V

    . Area under the maximum expiratory flow-volume curve: a sensitive parameter in the evaluation of airway patency. Respiration 2008;75(1):40–47.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Seppälä OP

    . Reproducibility of methacholine induced bronchoconstriction in healthy subjects: the use of area under the expiratory flow-volume curve to express results. Respir Med 1990;84(5):387–394.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Lee J,
    2. Lee CT,
    3. Lee JH,
    4. Cho YJ,
    5. Park JS,
    6. Oh YM,
    7. et al

    . Graphic analysis of flow-volume curves: a pilot study. BMC Pulm Med 2016;16:18.

    OpenUrlPubMed
14. 14.↵
    1. Quanjer PH,
    2. Stanojevic S,
    3. Cole TJ,
    4. Baur X,
    5. Hall GL,
    6. Culver BH,
    7. et al

    . Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40(6):1324–1343.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Mohamed Hoesein FA,
    2. Zanen P,
    3. Lammers JW

    . Lower limit of normal or FEV₁/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011;105(6):907–915.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Wollmer P,
    2. Engström G

    . Fixed ratio or lower limit of normal as cut-off value for FEV₁/VC: an outcome study. Respir Med 2013;107(9):1460–1462.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Arkin CF,
    2. Wachtel MS

    . How many patients are necessary to assess test performance? JAMA 1990;263(2):275–278.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Kapp MC,
    2. Schachter EN,
    3. Beck GJ,
    4. Maunder LR,
    5. Witek TJ Jr.

    . The shape of the maximum expiratory flow volume curve. Chest 1988;94(4):799–806.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Schachter EN,
    2. Kapp MC,
    3. Maunder LR,
    4. Beck G,
    5. Witek TJ

    . Smoking and cotton dust effects in cotton textile workers: an analysis of the shape of the maximum expiratory flow volume curve. Environ Health Perspect 1986;66:145–148.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Omland O,
    2. Sigsgaard T,
    3. Pedersen OF,
    4. Miller MR

    . The shape of the maximum expiratory flow-volume curve reflects exposure in farming. Ann Agric Environ Med 2000;7(2):71–78.

    OpenUrlPubMedWeb of Science
21. 21.
    1. Kraan J,
    2. van der Mark TW,
    3. Koëter GH

    . Changes in maximum expiratory flow-volume curve configuration after treatment with inhaled corticosteroids. Thorax 1989;44(12):1015–1021.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Mead J

    . Analysis of the configuration of maximum expiratory flow-volume curves. J Appl Physiol Respir Environ Exerc Physiol 1978;44(2):156–165.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Vermaak JC,
    2. Bunn AE,
    3. de Kock MA

    . A new lung function index: the area under the maximum expiratory flow-volume curve. Respiration 1979;37(2):61–65.

    OpenUrlPubMed
24. 24.
    1. Trzaska-Sobczak M,
    2. Pierzchala W

    . [Prediction of exercise capacity in chronic obstructive pulmonary disease patients on the basis of maximum expiratory flow-volume curve]. Pneumonol Alergol Pol 2007;75(3):213–218.

    OpenUrlPubMed
25. 25.
    1. Struthers AD,
    2. Addis GJ

    . Respiratory function measurements in clinical pharmacological studies including an assessment of the area under the MEFV curve as a new parameter in chronic bronchitic patients. Eur J Clin Pharmacol 1988;34(3):277–281.

    OpenUrlPubMed
26. 26.↵
    1. Kawamoto H,
    2. Kimura T,
    3. Kambe M,
    4. Miyamura I,
    5. Kuraoka T

    . [Significance of area under the flow volume curve: useful index of bronchial asthma]. Arerugi 1999;48(7):737–740.

    OpenUrlPubMed